Novartis' Ilaris Cleared for Gouty Arthritis in EU

Published March 3, 2013

Novartis' Ilaris cleared for gouty arthritis in EU

Filed under: crack symptoms

Gout has been a tricky indication for drug developers to crack, with the FDA turning down another CAPS treatment – Regeneron's IL-1 inhibitor Arcalyst (rilonacept) – in 2012 on the grounds of inadequate safety data and concern about a risk of malignancy. Read more on PMLiVE

Furnace heat exchanger crack – General insection of furnace found two large holes on heat exchanger.

Calcutta chronicles

Filed under: crack symptoms

Moreover, Calcutta, which was once emblematic of modernity, now abounded in symptoms of morbidity — urban dereliction, industrial stagnation, and the decline of Bengali language. … “I have not been able to crack the city and I make no bones about it. Read more on The Hindu